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Objectives: To assess the applicability ofplasma D-dimer levels in the exclusion of a DVT. 
Design: Consecutive cohort of patients. 
Materials and Methods: Eighty consecutive patients presenting to the radiology department with a clinical diagnosis 
of DVT were included. Citrated blood samples were taken from all patients before radiologicaI investigation, plasma 
isolated and frozen for subsequent testing. The patients then underwent venography (duplex scan was also used in some 
cases). Plasma samples were tested using the NycoCard D-Dimer. NycoCard Reader was used to estimate the D-dimer 
concentrations. 
Results: A DVT was diagnosed in 29 cases (36.7%). Plasma D-dimer levels had a sensitivity of 96% (only one false 
negative), specificity of 40%, positive predictive value of 48%, and negative predictive value of 95% when compared to 
venography. 
Conclusions: A normal plasma D-dimer level could be used as an exclusion test for DVT avoiding complications of 
venography and saving time and money. 
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Introduction 
Clinical diagnosis of deep vein thrombosis (DVT) is 
unreliable with an accuracy of approximately 50%. 1'2 
Approximately 50% of patients will therefore undergo 
investigation for DVT unnecessarily with either ven- 
ography or Doppler ultrasound. Venography, regarded 
as the "gold standard", has the advantage of being 
invasive, costly, time-consuming and demanding tech- 
nical expertise. 3 Furthermore, it is not without side- 
effects, 4 is less reliable in cases of recurrent DVT, 5 and 
may fail to visualise some segments of the venous 
system in 10-30% of cases. 6Doppler ultrasound (with 
an accuracy of 80-90% compared to venography) is
very operator-dependent. 6 For a blood test to be useful 
in a clinical setting for screening patients presenting 
with a suspected DVT it would have to be rapid, 
sensitive, and easy to perform. 
Once a thrombus has formed in the deep veins of 
the leg it is broken down by the fibrinolytic system. 
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D-dimers are unique fragments derived from fibrin 
by the hydrolytic action of plasmin. 7 Thus the presence 
of a thrombus may be associated with an increase 
in the plasma level of D-dimer. aD-dimer levels are, 
however, increased in a wide variety of conditions, 9 
and therefore cannot be used to predict he presence 
of a DVT. Normal levels of D-dimer may, however, 
be used to "rule out" DVT. 8 Various studies have 
confirmed that a low concentration f D-dimer meas- 
ured by the ELISA technique (usually less than 500 gg/ 
1) might be used to exclude clinically suspected venous 
thromboembolism. ~° Most of these assays were, how- 
ever, carried out in specialist research laboratories. 
The aim of this study was to determine the use- 
fulness of a rapid plasma immunofiltration assay 
(NycoCard D-Dimer) in excluding the diagnosis of a 
DVT in a clinical setting. 
Method 
Local ethical committee approval was obtained for the 
study. Eighty consecutive patients presenting to the 
radiology department with a presumptive diagnosis 
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Fig. 1. Diagram showing the structure ofthe NycoCard. 
of lower limb DVT were entered into the study after 
informed consent. All the patients were ambulatory, 
had not undergone surgery or major trauma nd were 
without significant underlying disease (e.g. cancer, 
rheumatoid arthritis etc.). The duration of symptoms 
was noted prior to presentation to the hospital, but 
once in hospital the radiological examination was car- 
ried out within 24 h. A 5 ml blood sample was collected 
into a sterile tube, containing sodium nitrate as anti- 
coagulant, before undergoing radiological tests. All 
patients were investigated with either venography 
or duplex scanning (combined with venography in 
uncertain cases - especially in cases of lower leg DVT). 
The extent of the DVT (calf or proximal) was noted. 
All investigations were carried out by consultant ra- 
diologists, experienced in venography and duplex 
scanning, blinded to the results of the D-dimer assay. 
Plasma was prepared from the citrated blood by 
centrifugation at 2500 g for 15 minutes and tested 
either on the same day or frozen and tested in batches. 
NycoCard D-Dimer (Nycomed (UK) Ltd) utilises a 
gold antibody conjugate in an immunofiltration test 
principle which produces a reddish purple colour 
at pathological D-dimer concentrations. The level of 
plasma D-dimer can be estimated in the range of 
0.5-8 mg/1. The main components of the card are 
shown in Figure 1. The thin porous membrane carries 
the monocl0nal ntibodies reacting with D-dimer-con- 
figured molecules. The assay is performed as follows: 
the membrane is activated by the addition of 50 gl of a 
washing solution, followed by 50 gl of citrated plasma 
sample. After the liquid has been taken up by the 
absorbent pad 50 gl of a conjugate between the same 
D-dimer-reactive antibody and 4 nm gold colloids is 
added, followed by 50 ~i of washing solution. The 
colour intensity was used to estimate the con- 
centrations of D-dimer. This was done with both a 
NycoCard Reader and visually using a reference colour 
chart with five zones of colour corresponding to D- 
dimer concentrations of 0.5, 1.0, 2.0, 4.0, and 8.0 rag/1. 
These measurements were performed by two in- 
dependent observers blinded to each other's results 
(one using the NycoCard Reader and the other using 
the visual reference chart). The entire test procedure 
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Fig. 2. Correlation between D-dimer levels as determined byvisual 
reading of the NycoCard and by using the NycoCard Reader. 
is completed in less than 2 rain. A NycoCard D-dimer 
concentration f <0.5 mg/1 was used to indicate normal 
levels (i.e. a negative test). 
Resu l ts  
Of the 80 specimens one was rejected because it was 
grossly lipaemic and would not filter through the 
porous membrane. Of the remaining 79 cases there 
were 31 men and 48 women with a median age (range) 
of 63 (32-89) years. Duration of symptoms prior to 
investigation was recorded in 32 cases and was a 
median (range) of 6.5 (2-90) days. A DVT was diag- 
nosed (using venography or duplex) in 29 (36.7%) of 
cases, 16 involving the calf veins only and 13 involving 
the iliofemoral segment as well. Venography alone 
was used in 71 cases, duplex scanning alone in six 
cases and both modalities in two cases. The two groups 
(DVT positive and negative) were well matched for 
sex ratio (Chi-squared test Z2=0.088; p>0.5) and age 
(Mann-Whitney test p = 0.62). However, some patients 
had already been started on treatment with intra- 
venous heparin. There were 14 (48.3%) in the DVT 
positive group and 13 (26%) in the DVT negative 
group (Z2=4.05; 0.02<p<0.05). 
Figure 2 shows the correlation between the D-dimer 
levels as determined by visual scoring against the 
NycoCard Reader. Although an excellent correlation 
is seen (r =0.977) on three occasions, visual reading 
was negative, whereas the NycoCard Reader gave a 
positive result. 
There was no correlation between duration of symp- 
toms and D-dimer levels, nor between duration of 
symptoms and the presence or absence of a DVT. 
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Table 1. Data showing DVT positive and negative cases against 
D-dimer test results. 
DVT positive DVT negative Total 
D-dimer positive* 28 30 58 
D-dimer negative** 1 20 21 
Total 29 50 79 
*D-dimer test was considered positive at levels _>0.5mg/1. 
**D-dimer test was considered negative at levels <0.5 rag/1. 
Table 1 shows the D-dimer levels against he radio- 
logical investigation results. Using this table the sensi- 
tivity was 96%, the specificity 40%, the positive 
predictive value 48%, and the negative predictive value 
95%. 
Discussion 
The usefulness of plasma D-dimer levels as an ex- 
clusion test for DVT has been recognised for some 
time and has been studied using commercially avail- 
able ELISA or latex agglutination tests. 1° Enzyme im- 
munoassays are precise, quantitative, analytical tools, 
but are time-consuming and require technical skill. 
The latex tests are simple and rapid, but are semi- 
quantitative and not easily readJ ~ The NycoCard em- 
ploys a filtration-type immunoassay that combines 
quantitative properties with rapidity and simple in- 
terpretation of results. It has been validated against 
an ELISA. 11'12 
Bounameaux et alJ ° have reviewed the results of 
ELISA against all diagnostic methods for DVT and 
report on average sensitivity of 96.8%, specificity of 
35.2%, positive predictive value of 44.3%, and negative 
predictive value of. 95.4%. The results obtained in our 
study are comparable to these. The NycoCard has 
been tested in a hospital setting by Dale et aI. 12 They 
report results similar to those in this study but with 
a lower specificity of 23% and negative predictive 
value of 87%. 
The effect of heparin needs to be considered. There 
were significantly more patients in the DVT positive 
group on heparin. Heparin has been reported to cause 
a decrease in the recovery of D-dimer using the Nyco- 
Card by Gogstad et al. 11 and to have no effect on D- 
dimer levels as measured by ELISA. ~3 The one patient 
who was negative on testing but in fact had no ilio- 
femoral DVT was on heparin. If heparin causes a 
decrease in the measured value of D-dimer, the level 
recorded would have been higher had the patient not 
been on heparin and the test would have been positive. 
One could, therefore, suggest hat all patients hould 
be tested before anticoagulation is started. This is 
clearly feasible as the test takes less than 2 min to 
perform. Overall, however, taking into account ime 
to deliver the specimen, centrifugation and testing the 
turnaround time is approximately I h. 
Of our sample of 79 patients, 20 underwent ven- 
ography, with its attendant complications, which could 
have been avoided had a D-dimer estimation been 
made. Furthermore, a saving could have been made 
in terms of money and of the radiologists' time. A 
venogram takes 20-30 min and costs approximately 
£65 per leg. Thus, of the 79 patients, 20 (25% of the case 
load) could have avoided venography - representing a 
saving of 10 h and £1300. These patients would also 
avoid exposure to radiation and the potential com- 
plications of venography. This compares to a cost 
of approximately £10 per D-dimer analysis in the 
department of haematology. The kits cost £125 for 48 
tests (£2.60 per test). 
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